# Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject

> **NCT05849883** · NA · COMPLETED · sponsor: **PT Kalbe Farma Tbk** · enrollment: 36 (actual)

## Conditions studied

- Drug Use

## Interventions

- **DRUG:** Omeprazole 20 mg Capsules

## Key facts

- **NCT ID:** NCT05849883
- **Lead sponsor:** PT Kalbe Farma Tbk
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-10
- **Primary completion:** 2021-01-14
- **Final completion:** 2021-02-03
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2023-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05849883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05849883, "Bioequivalence Study of 20 mg Omeprazole Capsules in Indonesia Healthy Subject". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05849883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*